$BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
XNAS
Why is BBOT up today? It is at $8.72 (+3.56%), and our scanner flagged it 3 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BBOT spikes, and full due diligence on BBOT — key stats, earnings, dilution and insider activity. Free.
Get free $BBOT alerts the moment volume spikes
Our scanner flagged $BBOT 3 times in the last 30 days. Create a free account to track $BBOT, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $8.72
- Change today
- +3.56%
- Previous close
- $8.42
- 52-week range
- $7.00 – $14.87
- Market cap
- $675M
- Total held
- 24.4%
- Tradeable float
- 60.6M 76% of shares · after 24% insiders + institutional n/a
- Short interest
- 5.2M ▲ +32% vs prior · as of 2026-06-30
- Short % of float
- 8.6%
- Days to cover
- 7.2d
- Avg daily volume
- 310K
- Next earnings
- Aug 11 · in 21d
- Exchange
- XNAS
Get free BBOT + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $BBOT up today?
BBOT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on BBOT today, peaking at 7.0x its normal volume.
Likely catalystExecutive / Board Change · Shareholder Vote, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
1 buys, 5 sells last 3 months (6/9 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Chen Bihua Director | Sold (automatic/other) | -4.53M 5.7% of company | n/a | n/a | n/a | Jul 1, 26 |
Chen Bihua Director | Acquired (grant/award) | +4.53M 5.7% of company | added 34% | 17.88M | n/a | Jul 1, 26 |
Ben Yong Officer | Sold (automatic/other) | -1K | sold 2.3% | 45K | $8K at $7.80 | Jul 1, 26 |
Beltran Pedro Officer | Sold (automatic/other) | -1K | sold 2.3% | 45K | $8K at $7.80 | Jul 1, 26 |
Elmelech Idan Officer | Sold (automatic/other) | -343 | sold 2.3% | 14K | $3K at $7.80 | Jul 1, 26 |
Cobo Marc Officer | Sold (automatic/other) | -125 | sold 2.3% | 5K | $975 at $7.80 | Jul 1, 26 |
Mehra Uneek Other | Sold (automatic/other) | -524 | sold 2.2% | 23K | $5K at $9.03 | Apr 1, 26 |
Beltran Pedro Officer | Sold (automatic/other) | -1K | sold 2.2% | 46K | $9K at $9.03 | Apr 1, 26 |
Ben Yong Officer | Sold (automatic/other) | -1K | sold 2.2% | 46K | $9K at $9.03 | Apr 1, 26 |
Ben Yong Officer | Acquired (grant/award) | +47K 0.06% of company | n/a | 47K | n/a | Mar 10, 26 |
Beltran Pedro Officer | Acquired (grant/award) | +47K 0.06% of company | n/a | 47K | n/a | Mar 10, 26 |
Mehra Uneek Officer | Acquired (grant/award) | +23K 0.03% of company | n/a | 23K | n/a | Mar 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $BBOT runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$BBOT Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$BBOT Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
BBOT stock FAQ
Why is $BBOT up today?
BBOT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on BBOT today, peaking at 7.0x its normal volume.
What is the BBOT stock price today?
BBOT last traded at $8.72, up 3.56% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does BBOT report earnings?
BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) is next expected to report earnings on Tuesday, August 11, 2026, about 21 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live BBOT alerts?
The BBOT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BBOT 3 times in the last 30 days.
What exchange is BBOT on?
BBOT (BridgeBio Oncology Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $675M.
Is BBOT good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BBOT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.